Multiple sclerosis immune/regenerative treatment
What kind of disease is multiple sclerosis?
Limitations of existing treatments and differences between LACELLIC
Why LACELLIC Hybrid Care is different
EvoNK + EvoStem combined package
Core treatment for multiple sclerosis proposed by LACELLIC
LACELLIC Multiple Sclerosis Medical Tour
LACELLIC Medical Tour Package
Multiple sclerosis is known as an autoimmune disease in which the body's immune system mistakenly attacks the central nervous system, damaging the myelin sheath surrounding nerve fibers.
Myelin is described as acting as an insulating layer that helps nerve signals travel quickly and accurately.
If the myelin sheath is damaged, signal transmission may be disrupted and various symptoms may appear, such as vision abnormalities, decreased sensation or numbness, muscle weakness, changes in balance, and severe fatigue.
It is mentioned as a characteristic that the area where symptoms appear varies from person to person and often shows a course of alternating deterioration and recovery.
When symptoms subside for a while, it is easy to accept that you have recovered, but it is also said that the burden on the nervous system can continue even in the meantime.
However, the disease cannot be diagnosed based on these symptoms alone. Confirmation through imaging tests such as MRI, cerebrospinal fluid testing, and neurologist treatment should be given priority. Methods that have been considered together so far
For multiple sclerosis, disease-modifying treatments, immunosuppressants, and acute-phase steroid treatment are widely used, and rehabilitation treatment and symptom-specific management are also recommended.
These treatments play an important role in slowing the progression of inflammation and managing the frequency of recurrences, and are planned and followed at the discretion of your healthcare provider.
On the one hand, as it is a disease that needs to be managed over a long period of time, research is continuing on approaches that look at both controlling inflammatory signals and the recovery environment of already burdened nervous tissue.
Immune cells and stem cells in our body - LACELLIC’s unique EvoNK·EvoStem hybrid
NK cells are immune cells that originally exist in our body and are known to play a role in recognizing abnormal cells and regulating immune responses.
Stem cells are cells with the ability to differentiate into various types of cells, and have been studied for a long time in relation to the environment in which damaged tissues are restored.
LACELLIC's EvoNK·EvoStem Hybrid is a program that combines these two. It consists of EvoNK, which regulates the immune response, and EvoStem, which monitors the regenerative environment of the entire body, including nervous tissue, through a combined intravenous (IV) method.
It is designed to minimize immune rejection by applying autologous platelet technology obtained from the patient's own blood. Here are the points we see together in the program:
• Control of chronic inflammatory signals heading to the central nervous system • Aim to create a recovery environment for damaged nerve myelin • Control of malfunctioning autoreactive immune cells • Induce immune tolerance rather than indiscriminate suppression •
This is a program designed from the perspective of re-establishing immune balance rather than unconditionally suppressing immunity.
However, for multiple sclerosis, the application and method vary depending on the location and extent of the lesion, the type of course, and the current systemic condition of the drug treatment already received.
Since the composition of a program and its applicability to a specific individual are two different issues, priority is given to the individual review process after sufficient testing and consultation with medical staff.
Also, please understand that this is not a concept to restore already damaged nerve function, but rather an approach aimed at slowing the progression and preserving remaining function.
Current standard treatment and regular follow-up rehabilitation treatment should be continued at the discretion of the medical staff, and the cell program is not a replacement for this. Do not stop taking the medication arbitrarily and be sure to consult your doctor.
Medical tour information for overseas patients
For overseas patients, not only medical treatment and treatment, but also the schedule before and after visiting Korea must be considered.
LACELLIC provides consultation regarding treatment schedules and medical tourism so that overseas patients can more conveniently prepare their domestic treatment schedule.
Movement and stay after arrival at the airport, remote tracking of immunity levels and follow-up care after returning home
Additionally, guidance on connecting with global partner networks in Southeast Asia, the Middle East, and the Americas is also provided.
The basic schedule is a one-time visit to Korea, from precise diagnosis to cell transplantation, and then repeated visit cycles and ongoing management based on the EvoX platform are reviewed. The specific scope of support may vary depending on the patient's schedule and program and can be confirmed through prior consultation.
The method of application of cell programs may vary depending on the individual's condition. LACELLIC also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff.
The scope of support for global partner network connections may vary depending on the partner organization and country, and may not be available in all regions. Treatment effectiveness may vary depending on the individual.
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
